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Summary
Background: Oxidative stress induced by superoxide anion
plays critical roles in the pathogenesis of coronary artery
disease (CAD) and hence acute myocardial infarction
(AMI). The major source of superoxide production in vas-
cular smooth muscle and endothelial cells is the NADPH
oxidase complex. An essential component of this complex
is p22phox, that is encoded by the cytochrome b-245,
alpha polypeptide (CYBA) gene. The aim of this study was
to investigate the association of CYBA variants (rs1049255
and rs4673) and premature acute myocardial infarction
risk in an Iranian population.
Kratak sadr`aj
Uvod: Oksidativni stres izazvan superoksidnim anjonom ima
va`ne uloge u patogenezi koronarne arterijske bolesti (KAB)
a time i akutnog infarkta miokarda (AIM). Glavni izvor pro-
dukcije superoksida u }elijama vaskularnog glatkog mi{i}a i
endotelnim }elijama je kompleks NADPH oksidaza. Va`na
komponenta ovog kompleksa je p22phox, koji kodira gen
citohrom b-245, alfa polipeptid (CYBA). Cilj ove studije bio
je da se ispita povezanost varijanti CYBA (rs1049255 i
rs4673) sa rizikom od prevremenog akutnog infarkta mio -
karda u jednoj populaciji Iranaca.
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Introduction
Acute myocardial infarction (AMI) is one of the
leading causes of morbidity and mortality in the
world. The most common cause of AMI is coronary
artery disease (CAD) that is a multifactorial disease,
resulting from genetic and environmental factors’
interaction (1). Evidence suggests that the elevated
levels of reactive oxygen species (ROSs), known as
oxidative stress, are the major contributor to patho -
logic cardiovascular states such as CAD (2, 3). 
Nicotinamide adenine dinucleotide phosphate
(NADPH) oxidases (Nox) represent a class of trans-
membrane hetero-oligomeric enzymes including five
Nox isoforms (Nox1, Nox2, Nox3, Nox4 and Nox5)
and two related enzymes (Duox1 and Duox2). The
primary function of these enzymes is the production
of reactive oxygen species (ROSs) such as superoxide
anion (O˚2) in many cells particularly endothelial and
vascular smooth cells (4, 5). Coupling components
such as p22phox, p47phox, p67phox, p40phox and
Rac are necessary for the activity and stabilization of
these isoforms. All Nox appear to have an essential
requirement for p22phox which is a heme binding
protein that is located in the membrane. p22phox is
composed of the a subunit of cytochrome b-245 and
acts as an electron transfer element of NADPH oxi-
dase. This subunit is encoded by the CYBA gene that
is located on chromosome 16q24 and spans 8.5 kb
(6 exons and 5 introns) (6). 
The association between CAD risk and several
polymorphic sites of the CYBA gene including C242T,
C549T, A640G and promoter polymorphisms was
investigated in previous studies (6). C242T (rs4673)
is located in position 273853 of the CYBA gene’s
exon 4. In this single nucleotide polymorphism (SNP)
the ancestral allele (T) is substituted by a (C) allele.
This substitution causes a missense mutation, result-
ing in the replacement of a histidine by a tyrosine at
the residue of 72 (7). Although there is supporting
evidence which suggests that C242T can attenuate
the oxidative function of NADPH oxidase, its actual
role in CAD pathology remains to be elucidated (8, 9).
The A640G polymorphism (rs1049255) is
located in the 3 untranslated region of CYBA, with no
amino acid substitution. It has been assumed that
A640G modifies the stability of p22phox mRNA and
translational activity of CYBA. A few studies have
investigated the relationship between the A640G
polymorphism and CAD, but controversy still exists
(10, 11). 
The present study aimed to investigate the pos-
sible association between C242T (rs4673) and
A640G (rs1049255) variants of the CYBA gene and
premature acute myocardial infarction risk in an
Iranian population.
Materials and Methods
Study population
Patient and control subjects were recruited from
the Shahid Rajaei Cardiovascular Center, Tehran, Iran.
The study population consisted of 158 patients under
the age of 50 years with a diagnosis of premature
AMI, and 168 age-matched controls who had all
undergone coronary angiography and had normal
coronary angiograms. Diagnosis of AMI was con-
firmed according to the new criteria of the American
College of Cardiology and the European Society of
Cardiology definition (12). Clinical information
including MI type (STEMI or NSTEMI), MI biomarkers
(troponin and creatine kinase-MB) were obtained
through medical records. The study was approved by
Methods: The study population consisted of 158 patients
under the age of 50 years, with a diagnosis of premature
AMI, and 168 age-matched controls with normal coronary
angiograms. Genotyping of the polymorphisms was per-
formed by the polymerase chain reaction and restriction
fragment length polymorphism (PCR-RFLP).
Results: There was no association between the genotypes
and allele frequencies of rs4673 polymorphism and pre-
mature acute myocardial infarction (P>0.05). A significant
statistical association was observed between the genotypes
dis tribution of rs1049255 polymorphism and AMI risk
(P=0.037). Furthermore, the distribution of AA+AG/GG
genotypes was found to be statistically significant between
the two groups (P=0.011).
Conclusions: Our findings indicated that rs1049255 but
not rs4673 polymorphism is associated with premature
AMI.
Keywords: acute myocardial infarction, p22phox, poly-
morphism, rs1049255, rs4673
Metode: Prou~avanu populaciju ~inilo je 158 pacijenata
mla|ih od 50 godina sa dijagnozom prevremenog AIM, i
168 kontrolnih ispitanika odgovaraju}e starosne dobi sa nor-
malnim koronarnim angiogramima. Genotipizacija polimor-
fizama je obavljena pomo}u reakcije lan~ane polimeraze i
polimorfizma du`ine restrikcionih fragmenata (PCR-RFLP).
Rezultati: Nije utvr|eno postojanje veze izme|u genotipova
i u~estalosti alela polimorfizma rs4673 i prevremenog akut -
nog infarkta miokarda (P>0,05). Zna~ajna statisti~ka po -
vezanost je uo~ena izme|u distribucije genotipova poli -
morfizma rs1049255 i rizika od AIM (P=0,037). [tavi{e,
distri bucija genotipova AA+AG/GG pokazala se kao statis -
ti~ki zna~ajna izme|u dve grupe (P=0,011).
Zaklju~ak: Na{i nalazi ukazuju na to da polimorfizam
rs1049255 jeste, ali rs4673 nije povezan sa prevremenim
AIM.
Klju~ne re~i: akutni infarkt miokarda, p22phox, polimor-
fizam, rs1049255, rs4673
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the Iran University of Medical Sciences’ Ethics
Committee and written informed consent was
obtained from all subjects.
Biochemical parameters
Blood samples were collected after fasting for
12 h. Serum levels of total cholesterol, triglyceride
and HDL-cholesterol were measured by routine
methods. LDL-cholesterol was estimated using the
Friedewald equation.
DNA extraction
Total genomic DNA was extracted from ethylene
diamine tetraacetic acid anticoagulated whole blood
by a salting out method (13, 14).
rs1049255 and rs4673 genotyping
Genotyping of rs4673 and rs1049255 variants
was performed by the PCR-RFLP technique. For
rs1049255, PCR amplification was done by Fast start
Taq polymerase (Roche) using a thermal cycler (Cor -
bet Research) in a final volume of 25 mL by the fol-
lowing primers: 5’-AGATCGGAGGCACCATCAAG-3’
(forward) and 5’-AGCTGTCAAGGG AGGACTCT-3’
(reverse). The cycling conditions were: 95 °C for 4
min followed by 30 cycles comprising 95 °C for 30 s,
annealing time at 62 °C for 45 s and extension at 72
°C for 45 s with a final extension time of 7 min at 70
°C. For the determination of rs1049255 genotypes,
PCR product (484 bp) was digested by 10 U of DraIII
restriction enzyme (New England Biolab) at 37 °C for
16 h. The resulting fragments were separated on 2%
agarose gel and visualized under a UV light after
staining with SYBR Green (CinnaGen DNA safe
Stain). These included a 484 bp fragment for the GG
homozygote, 484 bp, 295 bp and 189 bp fragments
for the AG heterozygote and 295 bp and 189 bp frag-
ments for the AA homozygote. 
Amplification of the DNA fragment containing
the rs4673 was performed using the forward 5’-
GTGTGTTTTGTGGGAGGAAAGA-3’ and reverse 5’-
TCCTCGGATTTGGAGTGGATC-3’ primers. DNA was
amplified for 30 cycles, each cycle including denatu-
ration at 95 °C for 30 s, annealing time at 59 °C for
45 s and extension at 72 °C for 40 s. For the deter-
mination of rs4673 genotypes, the PCR product (408
bp) was digested with 7 units RsaI (Fermentase) and
products were separated on 2% agarose gel. Three
possible genotypes were identified: subjects with the
TT genotype were identified by the presence of tow
products of 282 bp and 126 bp and those with the
CC genotype by the presence of one product (408
bp). Heterozygous subjects were identified by the
presence of three products of 408 bp, 282 bp and
126 bp.
Statistical analysis
Statistical analysis was performed by Statistical
Software Package for the Social Sciences (SPSS 18.0,
Chicago). The quantitative parameters in groups were
expressed as mean±SD and compared by Student’s
t-tests. Compatibility of genotype frequencies with
Hardy–Weinberg equilibrium expectations was
checked by chi-square goodness-of-fit test with one
degree of freedom. Moreover, the association
between categorical variables, such as genotype dis-
tributions and premature AMI was determined with
the c2 test. The odds ratios (ORs) and 95% confi-
dence intervals (CIs) were calculated as a measure of
the association of rs4673 (C/T) and rs1049255
(A/G) variants with AMI. Logistic regression analysis
was performed to find the significant predictors
among sex, family history of CAD, smoking, hyper-
tension, LDL-cholesterol, triglyceride, total cholesterol
and CYBA gene variants for CAD development risk. P
values which were less than 0.05 were considered to
be significant.
Results
Baseline characteristics of patient and control
subjects (158 patients and 168 controls) are summa-
rized in Table I. Data showed that the male sex was sig -
nificantly associated with premature AMI (P<0.001).
There were no significant differences in the serum
HDL-cholesterol level (P=0.06) and BMI (P=0.7)
between the groups whereas LDL-cholesterol
(P=0.001), total cholesterol (P=0.001) and triglyc-
eride (P=0.000) levels were significantly higher in
patients when compared to controls. 
The genotype distribution and allele frequencies
of rs1049255 and rs4673 are presented in Table II.
The distributions of the CYBA genotype and allele fre-
quencies in patient and control groups were com -
pliant with the Hardy–Weinberg equilibrium (all
P>0.05). Genotype distributions of rs4673 and its
allele frequencies had no significant differences
(P>0.05). Moreover, we did not find a significant dif-
ference in rs4673 TT+CT versus CC between the two
groups (P>0.05) (Figure 1). Significant statistical
association was observed between the genotype dis-
tributions and allele frequencies of rs1049255 poly-
morphism between patient and control subjects
(Table II). Furthermore, the difference of AA+AG/GG
genotype was found to be statistically significant
between the two groups (P=0.011) (Figure 1). Our
study did not confirm the association between the two
variants and AMI risk factors such as hypercholes-
terolemia and hypertension (P>0.05). 
Logistic regression analysis demonstrated that
male sex, hypertension and rs1049255 are signifi-
cant predictors for AMI risk. Our results showed that
there is no significant association between the other
studied predictors such as rs4673, smoking, hyper-
lipidemia and serum lipid profile (Table III).
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Table I Demographic and clinical characteristics of the
study population.
Parameter Control group(n=168)
Case group
(n=158) P
Sex (male/female) 68/100 122/36 0.000
Age (years) 44.7±6.8 46.32±5.2 0.07
Body mass index
(kg/m2) 25.58±3.43 26.57±5.45 0.07
STEMI – 115 –
NSTEMI – 43 –
Family history of
CAD 26 48 0.001
Hypertension 23 41 0.005
Hyperlipidemia 48 67 0.009
Smoking (yes/no) 56/112 77/81 0.001
LDL-cholesterol
(mmol/L) 5.19±1.50 5.77±1.71 0.001
HDL-cholesterol
(mmol/L) 2.24±0.49 2.14±0.51 0.06
Triglyceride
(mmol/L) 8.20±3.31 10.31±5.96 0.000
Total cholesterol
(mmol/L) 9.25±2.07 10.09±2.48 0.001
Table II Genotype distribution and relative allele frequen-
cies of rs1049255 and rs4673.
Genotypes Control group(n=168)
Case group
(n=158) P
rs1049255
GG 55 (32.7%) 32 (20.3%)
AG 76 (45.3%) 82 (51.9%)
AA 37 (22%) 44 (27.8%) 0.037
Allele 
frequency
G 186 (55.35%) 146 (46.2%)
A 150 (44.65%) 170 (53.8%) 0.019
Rs4673
CC 53 (31.54%) 56 (35.44%)
CT 81 (48.22%) 74 (46.83%)
TT 34 (20.24%) 28 (17.73%) 0.714
Allele 
frequency
C 187 (55.65%) 186 (58.86%)
T 149 (44.35%) 130 (41.13%) 0.408
Table III Logistic regression analysis results.
Logistic 
regression P OR 95% CI
Sex 0.001 7.830 3.853–15.912
Hypertension 0.013 2.403 1.202–4.806
Hyperlipidemia 0.324 1.348 0.745–2.438
Family history 
of CAD 0.348 1.354 0.719–2.548
Smoking 0 .697 0.878 0.455–1.692
HDL-cholesterol 0.146 0.978 0.949–1.008
LDL-cholesterol 0.242 1.009 0.994–1.024
Triglyceride 0.205 1.002 0.999–1.006
Cholesterol 0.503 1.004 0.993–1.015
rs4673 0.508 0.820 0.455–1.477
rs1049255 0.017 1.747 1.105–2.763
Figure 1 Genotype distribution for rs1049255
(AA+AG/GG) and rs4673 (TT+CT/CC). AA+AG/GG was
significantly higher among controls (P=0.011; OR 1.916;
CI 1.157–3.174) whereas TT+CT/CC distribution was not
significant between two groups (P>0.05).
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Discussion
The most common cause of AMI is CAD that is a
multifactorial disease, resulting from the interaction of
genetic and environmental factors (1, 15, 16).
Evidence over recent years has indicated that oxidative
stress induced by superoxide anion plays critical roles in
the pathogenesis of CAD and hence AMI. The major
source of superoxide production in vascular smooth
muscle and endothelial cells is the NADPH oxidase
complex (17). Among the subunits of NADPH oxidase,
there has been considerable interest in exploring the
possible disease-association of genetic variations in the
gene encoding p22phox (18). This subunit is encoded
by the CYBA gene. Several studies have been pub-
lished on the association between CYBA variants
including rs4673 (C242T) and rs1049255 (A640G)
and CAD development risk. However, the results are
controversial (19).
In the present study, we investigated the associ-
ation of CYBA variants (rs4673 and rs1049255) and
AMI in a case-control study. We could not detect a
significant effect for rs4673 polymorphism. There are
also other studies which showed no association signal
for rs4673 in AMI patients (11, 20, 21). The rs4673
relationship with cardiovascular pathologies was first
described by Inoue et al. in a Japanese population
(22). They studied 402 individuals (201 patients/201
controls) and observed a significantly decreased risk
of developing CAD in subjects carrying a T allele of
rs4673. Subsequently, this association was repro-
duced by Lee (23) and He (24) in Korean and
Chinese populations, respectively. Overall, the role of
rs4673 in AMI is not clear yet and studies with larger
sample size are necessary to resolve this controversy
(25).
The rs1049255 is located 3.4 kb downstream
to rs4673. Although one may think they are linked, a
strong linkage disequilibrium could not be found (r2:
0.09, D’: 0.35) (Figure 2). A statistically significant
association was observed between the rs1049255
polymorphism and AMI. The frequency of rs1049255
G allele was significantly higher in controls than in
patients with AMI (OR=1.916; 95% CI: 1.157–
406 Amin et al.: CYBA gene variants and myocardial infarction 
Figure 2 LD plot shows no strong linkage disequilibrium
between rs4673 and rs1049255. The plot was created by
Haploview using HapMap release 2 data.
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Figure 3 Position weight matrix for Lmo2 complex and
WT1 transcription factor binding site. (a) Canonical motif
for Lmo2 complex binding. (b) Canonical motif for WT1
binding.  The red rectangular in the sequence logo repre-
sents rs1049255 position in the relevant motif.
 
 
a 
b 
Table IV SNPs are in linkage disequilibrium with rs1049255.
Position (hg19) r2 D' Variant Motif changed GENCODE gene db SNP functionalannotation
Chr16:88709737 1 1 rs1049255 WT1, Lmo2 complex CYBA 3'-UTR
Chr16:88710833 0.8 0.92 rs3180279 HNF1 CYBA intronic
Chr16:88710882 0.8 0.92 rs3794622 AIRE, HNF4 CYBA intronic
Chr16:88710888 0.8 0.92 rs3794623 AIRE, HNF4 CYBA intronic
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3.174, P=0.011) (Figure 1). Our results are in agree-
ment with Gardemann et al. study (26). They report-
ed that the G allele had a protective role against coro-
nary artery disease in a German population. There
have been more investigations carried out to address
the role of rs1049255 polymorphism, but they failed
to show a significant association (6, 22, 24).
Under a logistic regression model, our analysis
showed that sex ratio is a significant predictor for AMI
risk (P=0.001). The male sex has an impressively
increased chance of developing AMI (OR for men vs.
women: 7.830). Furthermore, using a logistic regres-
sion model, we also found hypertension (OR: 2.403)
and rs1049255 (OR: 1.747) as two additional risk
factors for AMI in both men and women.
There are several lines of evidence that support
the rs1049255 potential functional relevance. The
ENCODE DNase footprinting assay experiments
revealed that rs1049255 (chr16: 88709736) located
at the 3’UTR of CYBA is a part of a canonical binding
motif for Lmo2 complex and WT1 transcription factor
(Figure 3) (27). Alternate substitution of A and G in
this site might affect transcription factors binding effi-
ciency. Moreover, it seems that histones H3 and H4
undergo different modifications around chr16:
88709736. The ENCODE chip-seq experiments con-
firmed that H3 and H4 undergo methylation and
acetylation in different cell types, around rs1049255.
Variations in base composition at such a location may
interfere with the recruitment of epigenetically impor-
tant DNA-binding proteins and hence contribute to
functional relevance (27). 
In addition to functional genomics data, popula-
tion genetics also supports rs1049255 functional re -
levance. Analysis of 1000 genome projects data
revealed that rs1049255 is in strong linkage disequi-
librium (r2 ≥ 0.8) with three other variants (Table IV)
which all have the potential to change transcription
factors binding motifs (28).
In conclusion, our findings indicate that
rs1049255 but not rs4673 polymorphisms are asso-
ciated with the risk of premature AMI. However, larg-
er studies should be carried out to confirm our results.
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